Caterina De Rosa

Naples, 80131, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

The evolving landscape of first-line and subsequent therapies in EGFR-mutated NSCLC: efficacy, resistance, and tolerability.

The evolving landscape of first-line and subsequent therapies in EGFR-mutated NSCLC: efficacy, resistance, and tolerability.

Journal: Exploration of targeted anti-tumor therapy

Published: December 30, 2025

Proof-of-concept study of clinical use of blood-based MAVS biosensor in predicting immunotherapy response in SCLC patients.

Proof-of-concept study of clinical use of blood-based MAVS biosensor in predicting immunotherapy response in SCLC patients.

Journal: Translational oncology

Published: October 14, 2025

Effect of Soluble Factors Released from Porcine Freeze-Dried Lung Tissue (FDLT) on Modulation of Cell Growth and EMT Signature in Non-Small Cell Lung Cancer (NSCLC)-A Preliminary In Vitro Study.

Effect of Soluble Factors Released from Porcine Freeze-Dried Lung Tissue (FDLT) on Modulation of Cell Growth and EMT Signature in Non-Small Cell Lung Cancer (NSCLC)-A Preliminary In Vitro Study.

Journal: International journal of molecular sciences

Published: October 08, 2025

Truncated PNA-functionalized porous silicon biosensor for low-cost and early detection of troponin T in myocardial infarction.

Truncated PNA-functionalized porous silicon biosensor for low-cost and early detection of troponin T in myocardial infarction.

Journal: Talanta

Published: September 02, 2025

Novel applications of liquid Biopsy: Comprehensive methodology for circulating biomarker exploration in peripheral blood.

Novel applications of liquid Biopsy: Comprehensive methodology for circulating biomarker exploration in peripheral blood.

Journal: The journal of liquid biopsy

Published: May 31, 2025

Effect of IL-1β on NSCLC-Derived Small Extracellular Vesicles as Actors in Mediating Cancer Progression and Evading Immune System.

Effect of IL-1β on NSCLC-Derived Small Extracellular Vesicles as Actors in Mediating Cancer Progression and Evading Immune System.

Journal: International journal of molecular sciences

Published: May 29, 2025

Synergistic effects of oncogene inhibition and pyruvate dehydrogenase kinase blockade in resistant NSCLC cells.

Synergistic effects of oncogene inhibition and pyruvate dehydrogenase kinase blockade in resistant NSCLC cells.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: March 24, 2025

Addition of metformin to anti-PD-1/PD-L1 drugs activates anti-tumor immune response in peripheral immune cells of NSCLC patients.

Addition of metformin to anti-PD-1/PD-L1 drugs activates anti-tumor immune response in peripheral immune cells of NSCLC patients.

Journal: Cell death & disease

Published: December 04, 2024

Combined Therapeutic Strategies Based on the Inhibition of Non-Oncogene Addiction to Improve Tumor Response in EGFR- and KRAS-Mutant Non-Small-Cell Lung Cancer.

Combined Therapeutic Strategies Based on the Inhibition of Non-Oncogene Addiction to Improve Tumor Response in EGFR- and KRAS-Mutant Non-Small-Cell Lung Cancer.

Journal: Cancers

Published: October 22, 2024

Corrigendum: Estrogens modulate somatostatin receptors expression and synergize with the somatostatin analog pasireotide in prostate cells.

Corrigendum: Estrogens modulate somatostatin receptors expression and synergize with the somatostatin analog pasireotide in prostate cells.

Journal: Frontiers in pharmacology

Published: October 22, 2024

DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer.

DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer.

Journal: iScience

Published: August 20, 2024

Discovery of N-substituted-2-oxoindolin benzoylhydrazines as c-MET/SMO modulators in EGFRi-resistant non-small cell lung cancer.

Discovery of N-substituted-2-oxoindolin benzoylhydrazines as c-MET/SMO modulators in EGFRi-resistant non-small cell lung cancer.

Journal: RSC medicinal chemistry

Published: July 17, 2024

Showing 1-12 of 22

Last Updated: 09/26/2026